BioSpace News Archive

Biomarck Pharmaceuticals, Ltd today announced that it is delighted to have been invited to present Phase 2 clinical data from its study in NSCLC and an update on the Phase 2 study in ARDS at the JPM conference.

ProciseDx today announced the attainment of CE mark for its Procise CRP assay (C reactive protein) which is the first of its family of gastrointestinal markers.

TauC3 Biologics Limited, a newly established privately held British biopharmaceutical company developing an innovative immunotherapy with the demonstrated potential to prevent the spread of tau pathology in the brain, today announced the appointments of Andrew J. Heath, MD, PhD as Non-Executive Chairman of its Board of Directors and Shafique Virani, MD as Non-Executive Director.

Each sample is identified by adding a unique index sequence to an NGS library, ensuring these libraries can be mixed and sequenced collectively.

Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Fluvoxamine Maleate Tablets in 25 mg, 50 mg and 100 mg strengths.

The strategic collaboration will see the expanded development of the wearable smart technology MOTIONSENSE™ and the data analytics of ORTHOLOGIQ® to improve patient care in orthopedic surgery

The patents cover Illumina’s proprietary sequencing-by-synthesis chemistry.

The presentation will take place on Thursday, January 16, 2020 at 11:00am PST.

Twinlab Consolidated Holdings, Inc. announced that it has successfully completed a long awaited ERP system upgrade, choosing Oracles NetSuite platform to help sustain its current growth trajectory into the future.

Alydia Health, a clinical-stage medical device company developing an innovative technology to prevent maternal morbidity and mortality caused by abnormal postpartum bleeding and hemorrhage, today announced that Erica Rogers has been appointed to the company’s board of directors as a strategic advisor.